Anthem (NYSE:ANTM – Get Rating) had its price objective lifted by stock analysts at Deutsche Bank Aktiengesellschaft from $453.00 to $574.00 in a research report issued to clients and investors on Friday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 9.78% from the stock’s previous close.
A number of other equities research analysts have also issued reports on ANTM. The Goldman Sachs Group increased their price target on Anthem from $527.00 to $605.00 and gave the company a “buy” rating in a research report on Thursday. Argus raised their target price on Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, February 7th. Morgan Stanley raised their target price on Anthem from $518.00 to $607.00 and gave the stock an “overweight” rating in a research report on Thursday. Jefferies Financial Group raised their target price on Anthem from $575.00 to $625.00 in a research report on Thursday. Finally, UBS Group raised their target price on Anthem from $477.00 to $541.00 and gave the stock a “buy” rating in a research report on Tuesday, March 29th. Two equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $534.05.
ANTM stock opened at $522.87 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.47 and a quick ratio of 1.47. The firm has a market capitalization of $132.42 billion, a P/E ratio of 21.15, a P/E/G ratio of 1.46 and a beta of 1.05. The business’s 50-day moving average is $478.89 and its two-hundred day moving average is $447.57. Anthem has a 1 year low of $355.43 and a 1 year high of $533.68.
In related news, CAO Ronald W. Penczek sold 2,423 shares of the company’s stock in a transaction on Thursday, March 3rd. The stock was sold at an average price of $463.68, for a total transaction of $1,123,496.64. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Peter D. Haytaian sold 17,703 shares of the company’s stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $460.71, for a total value of $8,155,949.13. The disclosure for this sale can be found here. Insiders have sold 22,889 shares of company stock worth $10,532,411 in the last ninety days. 0.27% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of ANTM. Norges Bank purchased a new stake in Anthem during the fourth quarter worth $1,128,341,000. Altshuler Shaham Ltd purchased a new stake in shares of Anthem in the third quarter valued at $381,379,000. Invesco Ltd. lifted its position in shares of Anthem by 29.4% in the third quarter. Invesco Ltd. now owns 2,955,310 shares of the company’s stock valued at $1,101,739,000 after acquiring an additional 671,275 shares in the last quarter. UBS Asset Management Americas Inc. lifted its position in shares of Anthem by 51.4% in the third quarter. UBS Asset Management Americas Inc. now owns 1,732,684 shares of the company’s stock valued at $645,945,000 after acquiring an additional 588,390 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its position in shares of Anthem by 14.7% in the fourth quarter. Baillie Gifford & Co. now owns 4,582,312 shares of the company’s stock valued at $2,124,085,000 after acquiring an additional 587,649 shares in the last quarter. Institutional investors own 87.97% of the company’s stock.
Anthem Company Profile (Get Rating)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
- Get a free copy of the StockNews.com research report on Anthem (ANTM)
- Should You Buy Carvana or AutoNation or Pass on Both?
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
- What Should Investors Take Away From Boston Beer’s Earnings?
- High-Yield Kinder Morgan Is Still A Buy
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.